Maverick AI vs RapidClaims
Two Autonomous Medical Coding vendors, side by side. Facts from public sources; judgments are ours.
At a glance
Derived from public facts · a rough scale, not a ranking
| Maverick AI | RapidClaims | |
|---|---|---|
| Pricing model | Not published · custom, tied to coding volume | Not published |
| Speed to go live | customers typically live within 90 days | Claims six weeks to production via API |
| Automation model | Autonomous agents · direct-to-bill autonomous coding | Autonomous agents · Human review on low-confidence charts |
| Built for | Mid-size groups, Enterprise systems, Billing companies | Mid-size groups, Enterprise systems, Billing companies |
| Security posture | HIPAA | SOC 2 Type II, HITRUST, HIPAA |
| Company maturity | 7 yrs (est. 2019) | 3 yrs (est. 2023) |
| Financial backing | $11.5M (per PitchBook) · Seed plus strategic investment | $11M · Series A |
| Named customers | 1 named | None public |
| Published results | Specific numbers public | Specific numbers public |
| Documented integrations | 1 listed | 5 listed |
| Third-party validation | None found | None found |
Bottom line
- Pick Maverick AI if you want charts coded and sent to billing without human coders, with 85 percent direct-to-bill.
- Pick RapidClaims if you want one AI platform spanning coding, scrubbing, and denials rather than a standalone coding engine.
Maverick AI
Real-time autonomous medical coding for revenue cycle teams
- Founded
- 2019
- HQ
- n/a
- Stage
- Seed plus strategic investment
- Raised
- $11.5M (per PitchBook)
What it does
- Real-time autonomous coding via the mCoder platform
- 85%+ direct-to-bill rate without human touch
- Codes most cases in seconds
- Reported 95% coding accuracy
- Streams coded results straight to billing systems
Where it's strong
- Real-time coding with a published 85%+ direct-to-bill rate, ahead of the batch processing common in the category.
- Proven at national scale through the RadNet implementation across US imaging sites.
- The Infinx investment and partnership give it a distribution channel into established RCM operations.
What buyers should weigh
- Widely cited reports of a $47M 2025 raise belong to competitor Nym, not Maverick; Maverick's disclosed funding is about $11.5M, so weigh vendor financial durability.
- Public proof points are concentrated in radiology; ask for evidence in other specialties.
- Roughly 15% of cases still route to human coders, so plan for a review workflow.
Named customers
RadNet
Integrations
RapidClaims
Autonomous AI coding and claim scrubbing across the revenue cycle
- Founded
- 2023
- HQ
- New York, NY
- Stage
- Series A
- Raised
- $11M
What it does
- Autonomous coding across 20+ specialties (RapidCode)
- Pre-bill claim scrubbing and edits
- Clinical documentation improvement prompts
- Denial management and appeals (RapidRecovery)
- AR follow-up within one workflow
- Audit trails for every coded chart
Where it's strong
- Covers documentation through denial appeal in one platform, so you avoid stitching point tools.
- Claims 98% coding accuracy with production deployment in about six weeks.
- Reference results include a 30% A/R day reduction and 40% lower coding cost.
What buyers should weigh
- No customers are publicly named, so reference checks require NDA conversations.
- At $11M raised it is earlier-stage than incumbent coding vendors.
- Accuracy claims are self-reported; validate on your own specialty mix in a pilot.
Integrations
Compare against the rest of Autonomous Medical Coding
Deciding between these two?
First Pass tracks Autonomous Medical Coding every week: funding, launches, and what changed since this page was written.